Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Drug Discovery & Development » Duke Researchers Propose Combination Therapy for PIK3CA-Mutant Breast Cancer

Duke Researchers Propose Combination Therapy for PIK3CA-Mutant Breast Cancer

Dec 14, 2016
|
staff reporter

NEW YORK (GenomeWeb) – A Duke University team has found early evidence that breast cancer cases marked by PIK3CA mutations may be vulnerable to combined treatments targeting programmed cell death and mTOR signaling pathways.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
01
Featured Webinar

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
02
Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Cancer

  1. Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021

  2. European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer

    Premium

  3. Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves

    Premium

  4. BTIG Initiates Coverage of Oncocyte With Buy Rating

  5. Genetron Health, Wuxi Government Form Joint Venture for Liver Cancer Screening Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.